Cargando…
Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350330/ https://www.ncbi.nlm.nih.gov/pubmed/34401426 http://dx.doi.org/10.1016/j.jdcr.2021.06.028 |
_version_ | 1783735737005375488 |
---|---|
author | Buttgereit, Thomas Grekowitz, Eva Maria Metz, Martin |
author_facet | Buttgereit, Thomas Grekowitz, Eva Maria Metz, Martin |
author_sort | Buttgereit, Thomas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8350330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83503302021-08-15 Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab Buttgereit, Thomas Grekowitz, Eva Maria Metz, Martin JAAD Case Rep Case Report Elsevier 2021-07-09 /pmc/articles/PMC8350330/ /pubmed/34401426 http://dx.doi.org/10.1016/j.jdcr.2021.06.028 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Buttgereit, Thomas Grekowitz, Eva Maria Metz, Martin Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title | Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title_full | Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title_fullStr | Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title_full_unstemmed | Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title_short | Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
title_sort | baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350330/ https://www.ncbi.nlm.nih.gov/pubmed/34401426 http://dx.doi.org/10.1016/j.jdcr.2021.06.028 |
work_keys_str_mv | AT buttgereitthomas baricitinibrapidlyandsustainablyrelievesapatientfromchronicpruritusofunknownoriginrefractorytodupilumab AT grekowitzevamaria baricitinibrapidlyandsustainablyrelievesapatientfromchronicpruritusofunknownoriginrefractorytodupilumab AT metzmartin baricitinibrapidlyandsustainablyrelievesapatientfromchronicpruritusofunknownoriginrefractorytodupilumab |